CD14 and peripheral arterial disease: Wildgruber et al., in a study of patients with severe peripheral artery disease, showed an increase in the proportion of the "intermediate" monocyte subpopulation CD14 ++CD16 +, which has enhanced pro-inflammatory activity [15].